---
schema_version: "secwatch.filing_event.v1"
accession: "0001933414-24-000017"
form_type: "8-K"
ticker: "MLYS"
cik: "0001933414"
company_name: "Mineralys Therapeutics, Inc."
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:52:45.004311+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders elect Jon Congleton as Class I director and ratify Ernst & Young as auditor at 2024 annual meeting

## Summary
- Proposal 1: Jon Congleton elected as Class I director with 26,418,385 votes for, 3,775,533 withheld, 1,838,014 broker non-votes.
- Proposal 2: Ratification of Ernst & Young as independent auditor approved with 32,025,366 for, 1,187 against, 5,379 abstain.
- Annual meeting held May 22, 2024; both proposals passed with requisite votes.

## SEC filing metadata
- accession: 0001933414-24-000017
- form_type: 8-K
- ticker: MLYS
- cik: 0001933414
- company_name: Mineralys Therapeutics, Inc.
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000017/0001933414-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000017/mlys-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001933414-24-000017
- JSON: https://secwatch.observer/filing/0001933414-24-000017.json
- Plain text: https://secwatch.observer/filing/0001933414-24-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.